Canagliflozin for the Treatment of Diabetic Kidney Disease and Implications for Clinical Practice: A Narrative Review

Type 2 diabetes mellitus (T2DM) affects millions of people worldwide, elevating their risk of developing a range of complications, including chronic kidney disease (CKD). People with T2DM and CKD (i.e., diabetic kidney disease, DKD) have an increased risk of progressing to end-stage kidney disease (...

Descripción completa

Detalles Bibliográficos
Autores principales: Kruger, Davida, Valentine, Virginia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261301/
https://www.ncbi.nlm.nih.gov/pubmed/32405876
http://dx.doi.org/10.1007/s13300-020-00826-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261301/
https://www.ncbi.nlm.nih.gov/pubmed/32405876
http://dx.doi.org/10.1007/s13300-020-00826-w

Ejemplares similares